<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03505541</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00002972</org_study_id>
    <nct_id>NCT03505541</nct_id>
  </id_info>
  <brief_title>Adipokines Effect in Myometrial Contractility</brief_title>
  <official_title>Effect of Adiponectin and TNFa on Uterine Contractility in GDM and Obese Pregnant Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Minnesota - Clinical and Translational Science Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Minnesota - Clinical and Translational Science Institute</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigate the effect of two adipokines which are adiponectin and TNFa on the force of
      myometrial contractility in diabetic, non-obese pregnant women and obese, non-diabetic term
      pregnant women at the time of scheduled cesarean delivery
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 1, 2018</start_date>
  <completion_date type="Anticipated">September 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Effect on force of contractility</measure>
    <time_frame>24 hours</time_frame>
    <description>Determine the effect of adiponectin and TNFa on the force of myometrial contractility in diabetic, non-obese pregnant women and obese, non-diabetic term pregnant women at the time of scheduled cesarean delivery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Force of contractility between study groups</measure>
    <time_frame>24 hours</time_frame>
    <description>Compare the force of myometrial contractility in study groups compared to control group (non-DM, non-obese term pregnant patients)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Progesterone effect in control group</measure>
    <time_frame>24 hours</time_frame>
    <description>Investigate the anti-inflammatory properties of Progesterone (P4) and 17a-Hydroxyprogesterone (HPC) on Adiponectin induced myometrial contractility in control group</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Myometrium; Contractility</condition>
  <condition>GDM</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <description>Healthy, term, non-obese (BMI &lt; 30) pregnant women with a singleton gestation scheduled for CS delivery at 37-41 weeks of gestation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Study group 1</arm_group_label>
    <description>Term pregnant, non-obese (BMI &lt;30), diagnosed with gestational diabetes, scheduled for CS delivery between 37-41 weeks of gestation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Study group 2</arm_group_label>
    <description>Term pregnant, obese (BMI &gt;30), non-diabetic and scheduled for CS delivery between 37-41 weeks of gestation</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Adiponectin and TNFa</intervention_name>
    <description>Adiponectin and TNFa are adipokines. Will be added to the myometrial biopsies to investigate their effect on the force of contractility</description>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_label>Study group 1</arm_group_label>
    <arm_group_label>Study group 2</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Pregnant subjects undergoing a scheduled C-section delivery.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant patients scheduled for a CS at 37-41 weeks of gestation at M Health Birth
             Place

          -  Participants age â‰¥18.

          -  Full informed consent able to be provided by the participant.

        Exclusion Criteria:

          -  Patients undergoing general anesthesia for their CS.

          -  Pre-gestational DM, and DM diagnosed &lt;24 weeks gestation.

          -  Patients unable to consent for themselves

          -  Multiple gestation
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Katherine Jacobs, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Minnesota - Clinical and Translational Science Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>hiba mustafa, MD</last_name>
    <phone>8324754061</phone>
    <email>musta062@umn.edu</email>
  </overall_contact>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 12, 2018</study_first_submitted>
  <study_first_submitted_qc>April 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 23, 2018</study_first_posted>
  <last_update_submitted>April 24, 2018</last_update_submitted>
  <last_update_submitted_qc>April 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

